About
Careers
Find
Podcasts
Blogs
Support & resources
Community

Search:

Tag: TRAILBLAZER-ALZ 2

Positive Results on Donanemab Phase 3 Trial Reported

Research News

Positive Results on Donanemab Phase 3 Trial Reported

17/07/2023 Alzheimer's Association

Delivered by University College London, with funding from the National Institute for Health and Care Research, Alzheimer's Association, Alzheimer’s Research UK, Alzheimer’s Society & Race Against Dementia.

NIHR | National Institute of Health Research

About
Acknowledgements
Privacy Policy
Cookie Policy
Comments Policy
Accessibility Statement
Equality, Diversity & Inclusion
Advertise
Contact Us
Help

Translate »